首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1593504

生物晶片市場規模、佔有率和成長分析（按類型、製造技術、應用、最終用戶、地區）：產業預測（2024-2031）

Biochips Market Size, Share, Growth Analysis, By Type (DNA Chips, Lab-On-A-Chip), By Fabrication Technology (Microarrays, Microfluidics), By Application (Genomics, Drug Development), By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月09日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球生物晶片市場規模估值為95.3億美元，從2023年的107.4億美元成長到2031年的279.1億美元，在預測期間（2024-2031年預計複合年成長率為12.68%，2019年）。

實驗室晶片和微陣列（生物晶片）市場正在經歷顯著的快速成長，這主要是由新型冠狀病毒感染疾病（COVID-19）的傳播所推動的，擴大了病毒相關診斷和研究對這些技術的需求。我正在實現它。展望未來，由於對 PoC 測試解決方案的需求不斷增加、慢性病患病率上升以及蛋白質組學和基因組學在癌症研究中的應用不斷擴大，預計該市場將保持其成長軌跡。促成這一市場擴張的關鍵因素包括主要企業先進診斷測試的開發、全球慢性病負擔以及生物晶片在蛋白質組學研究中的越來越多的使用。慢性病是導致殘疾和死亡的主要原因，尤其是在老齡化社會中，並且是實驗室晶片的系統進行有效診斷的研究和創新的驅動力。此外，生物晶片由於其優點而在生物醫學和生物技術領域越來越受歡迎，例如減少樣品需求和促進全面蛋白質組分析的能力，這對於生物標記和藥物發現工作至關重要。值得注意的是，包括針對 COVID-19的取得專利的診斷檢測在內的創新產品的核准對市場動態產生了積極影響，增強了其強勁的成長潛力。隨著生物晶片技術和診斷應用的不斷進步，這個快速成長的市場將為相關人員提供充足的商機。

市場概況
DNA晶片
- 基因表現
- SNP基因型鑒定
- 癌症診斷/治療
- 基因組學
- 藥物發現
- 農業生物技術
- DNA晶片的其他用途
實驗室晶片(LOAC)
- 臨床診斷
- 基因組學
- IVD,PoC
- 蛋白質體學
- 藥物發現
- 其他實驗室晶片應用
蛋白質晶片晶片
- 蛋白質體學
- 表達譜
- 診斷
- 高通量篩檢
- 藥物發現
- 其他蛋白質晶片應用
其他陣列
- 單元陣列
- 組織陣列

生物晶片市場：依製造技術分類

市場概況
微陣列
微流體

生物晶片市場：依應用分類

市場概況
基因組學
藥物開發
農業
其他

生物晶片市場：依最終用戶分類

市場概況
生物技術和製藥公司
醫院/診斷中心
學術研究所
其他最終用戶

生物晶片市場：按地區

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲 (MEA)
- 波灣合作理事會(GCC) 國家
- 南非
- 其他中東/非洲

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Abbott Laboratories
Agilent Technologies, Inc.
PerkinElmer, Inc.
Standard BioTools Inc.
Illumina, Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation
Thermo Fisher Scientific, Inc.
Roche Diagnostics
Micronit Microtechnologies
Randox Laboratories Ltd.
RayBiotech, Inc.
Invitae
CapitalBio Corporation
Genscript Biotech Corp
Takara Bio Usa Holdings, Inc.

簡介目錄

Product Code: SQMIG45A2235

Global Biochips Market size was valued at USD 9.53 billion in 2022 and is poised to grow from USD 10.74 billion in 2023 to USD 27.91 billion by 2031, growing at a CAGR of 12.68% during the forecast period (2024-2031).

The lab-on-a-chip and microarrays (biochips) market is witnessing a significant surge, largely driven by the COVID-19 pandemic, which amplified the demand for these technologies in diagnostics and research related to the virus. As we move forward, the market is set to continue its growth trajectory, propelled by the increasing demand for point-of-care testing solutions, the rising prevalence of chronic diseases, and the expanding application of proteomics and genomics in cancer research. Key factors contributing to this market expansion include a strong focus on the development of advanced diagnostic tests by leading companies, the global burden of chronic diseases, and the growing utilization of biochips in proteomics studies. Chronic diseases remain a major contributor to disability and mortality rates, particularly among the aging population, driving research and innovation in lab-on-a-chip-based systems for effective diagnosis. Furthermore, biochips are gaining traction within biomedical and biotechnological sectors due to their advantages, such as lower sample requirements and their ability to facilitate comprehensive proteome analyses, crucial for biomarker and drug discovery initiatives. Notably, the approval of innovative products, including patented diagnostic assays for COVID-19, has positively influenced market dynamics, reinforcing its robust growth potential. As the landscape evolves, the ongoing advancements in biochip technology and diagnostic applications are set to create ample opportunities for stakeholders in this burgeoning market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biochips market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biochips Market Segmental Analysis

Global Biochips Market is segmented by Type, Fabrication Technology, Application, End User, and Region. Based on Type, the market is segmented into DNA Chips (Gene Expression, SNP Genotyping, Cancer Diagnosis & Treatment, Genomics, Drug Discovery, Agricultural Biotechnology, Other DNA Chip Applications), Lab-On-A-Chip (Clinical Diagnostics, Genomics, IVD & POC, Proteomics, Drug Discovery, Other Loac Applications), Protein Chips (Proteomics, Expression Profiling, Diagnostics, High-Throughput Screening, Drug Discovery, Other Protein Chip Applications), Other Arrays (Cell Arrays, Tissue Arrays). Based on Fabrication Technology, the market is segmented into Microarrays, Microfluidics. Based on Application, the market is segmented into Genomics, Drug Development, Agriculture, and Others. Based on End User, the market is segmented into Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic & Research Institutes, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biochips Market

The ongoing advancements in genomics and proteomics are significant market drivers for the Global Biochips market, as they enable deeper insights into individual genetic profiles and disease mechanisms. The escalating demand for personalized medicine is prompting healthcare providers to seek targeted and tailored medical interventions, where biochips are essential. These devices facilitate the rapid and efficient analysis of vast datasets, allowing for the identification of critical genetic mutations and biomarkers linked to various diseases. Consequently, the enhancement of patient outcomes through personalized treatment plans is propelling the adoption of biochips in clinical settings, further stimulating market growth.

Restraints in the Global Biochips Market

The Global Biochips market faces significant restraints primarily due to the high costs associated with the development and implementation of advanced biochip technologies. Creating accurate and reliable biochips demands substantial financial investment and lengthy development timelines, which can deter potential manufacturers and users alike. Furthermore, integrating these sophisticated devices into existing healthcare systems and laboratory environments often necessitates additional capital outlay for infrastructure upgrades and maintenance. These financial burdens may hinder some healthcare facilities from adopting biochips widely. Nevertheless, as technological innovations continue to emerge and production efficiencies improve, the associated costs are likely to decrease, fostering greater market acceptance over time.

Market Trends of the Global Biochips Market

The Global Biochips market is witnessing a significant trend towards personalized medicine and precision diagnostics, driven by rapid advancements in genomics and proteomics. As healthcare evolves, the demand for customized medical treatments based on individual genetic profiles is intensifying. Biochips, known for their capacity to process large volumes of genetic and protein data, are central to this transformation. Their integration with cutting-edge technologies like artificial intelligence and machine learning enhances the development of advanced diagnostic tools and tailored therapeutic solutions. This trend is facilitating more accurate identification of genetic mutations and disease biomarkers, ultimately fostering improved patient outcomes and driving market growth.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Technology Analysis
Patent Analysis
Regulatory Landscape
PESTEL Analysis

Biochips Market, By Type

Market Overview
DNA Chips
- Gene Expression
- SNP Genotyping
- Cancer Diagnosis & Treatment
- Genomics
- Drug Discovery
- Agricultural Biotechnology
- Other DNA Chip Applications
Lab-On-A-Chip
- Clinical Diagnostics
- Genomics
- IVD & POC
- Proteomics
- Drug Discovery
- Other Loac Applications
Protein Chips
- Proteomics
- Expression Profiling
- Diagnostics
- High-Throughput Screening
- Drug Discovery
- Other Protein Chip Applications
Other Arrays
- Cell Arrays
- Tissue Arrays

Biochips Market, By Fabrication Technology

Market Overview
Microarrays
Microfluidics

Biochips Market, By Application

Market Overview
Genomics
Drug Development
Agriculture
Others

Biochips Market, By End User

Market Overview
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostics Centers
Academic & Research Institutes
Other End Users

Biochips Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Standard BioTools Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micronit Microtechnologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RayBiotech, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invitae
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CapitalBio Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genscript Biotech Corp
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Usa Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments